FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Twice-Daily Weight Loss Drug Stalls: Pfizer

Based on high discontinuation rates in a just-reported clinical trial, Pfizer says it will not advance its twice-daily weight-loss drug danuglipron in...

latest-news-card-1
Human Drugs

Epcoritamab Breakthrough Status in Follicular Lymphoma

FDA grants Genmab a breakthrough therapy designation for epcoritamab, an investigational T-cell engaging bispecific antibody administered subcutaneous...

latest-news-card-1
Medical Devices

BD Recalls Pumps Over Syringe Incompatibility

Becton Dickinsons Carefusion unit recalls (Class 1) its Alaris Infusion Pumps due to compatibility issues with Cardinal Health Monoject syringes.

latest-news-card-1
Federal Register

Info Collection on Compounder Registration

Federal Register notice: FDA sends to OMB an information collection extension for the registration of human drug compounding outsourcing facilities.

latest-news-card-1
Federal Register

Class 3 for Certain Wound Dressings

Federal Register notice: In separate rulemakings, FDA proposes to classify into Class 3 certain types of wound dressings and liquid wound washes conta...

latest-news-card-1
Human Drugs

FDA Fast Track for eFFECTORs Zotatifin

FDA grants fast-track designation to eFFECTOR Therapeutics for its zotatifin in combination with two other drugs as a second- or third-line treatment ...

latest-news-card-1
Medical Devices

FDA Checking Chinese Syringe Safety

FDA says it is evaluating possible safety issues with some plastic syringes manufactured by several firms in China.

latest-news-card-1
FDA General

Chief Scientist Tapped as Woodcock Replacement

FDA commissioner Robert Califf names agency chief scientist Namandj Bumpus as the replacement for retiring principal deputy commissioner Janet Woodcoc...

latest-news-card-1
Human Drugs

More Novo Nordisk Semaglutide Legal Actions

Novo Nordisk says it is seeking legal action against two compounding pharmacies it says are selling adulterated and misbranded drugs claiming to conta...

latest-news-card-1
Human Drugs

AbbVie Seeks Accelerated OK for Lung Cancer Drug

Based on new clinical study data, AbbVie says it will seek accelerated approval for telisotuzumab-vedotin in patients with c-Met protein overexpressio...